Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,031
Closed -$31.5K 10517
2024
Q4
$31.5K Sell
10,031
-79,769
-89% -$386K ﹤0.01% 9072
2024
Q3
$443K Sell
89,800
-114,237
-56% -$590K ﹤0.01% 7404
2024
Q2
$900K Sell
204,037
-165,159
-45% -$774K ﹤0.01% 5961
2024
Q1
$2.49M Buy
369,196
+335,568
+998% +$2.55M ﹤0.01% 3742
2023
Q4
$251K Buy
+33,628
New +$287K ﹤0.01% 7886
2023
Q3
Sell
-9,695
Closed -$206K 9320
2023
Q2
$203K Buy
+9,695
New +$198K ﹤0.01% 7662

Other funds holding SLRN

Jane Street's SLRN Position: Q1 2025 in Review

Jane Street sold out of ACELYRIN (SLRN) in Q1 2025, closing a stake of 10,031 shares — an estimated $31.5K sold.

Jane Street first reported a position in SLRN in Q2 2023 and held it in 6 quarters. The position peaked at $2.49M in Q1 2024. 105 funds tracked by Wall St. Rank hold SLRN as of Q1 2025.

  • Jane Street reported no remaining ACELYRIN position as of Q1 2025 after selling out during the quarter.
  • Jane Street sold 10,031 ACELYRIN shares in Q1 2025, an estimated $31.5K.
  • Jane Street first reported a position in ACELYRIN in Q2 2023 and held it in 6 quarters.
  • Jane Street's ACELYRIN position peaked at $2.49M in Q1 2024.
  • 105 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.